Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes.
Carmen Gonzalez San-SegundoJ JovéA ZapateroJ Pastor-PeidroM L VázquezM CasañaJ L MengualA Gómez-CaamañoA Gómez-IturriagaC VallejoI HenríquezJ L Muñoz-GarcíaJ ClementeM PorrasE ColladoG OssolaE VillafrancaM A CabezaJ López-TorrecillaPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)
In PCa treated with radiotherapy, median survival after BF is relatively long. In this sample, no differences in survival rates at 8-years have been found, regardless of the time of radiotherapy administered. AD was the most common treatment after BF. Metastases and high Gleason score are adverse variables. To our knowledge, this is the first study to compare outcomes after BF among patients treated with primary RT vs. those treated with postoperative RT and to evaluate recurrence patterns, treatments administered, and causes of death. The results allow avoiding overtreatment, improving quality of life, without negatively affecting survival.